Skip to main content

Natalie Scholpa Receives the ABRC New Investigator Award

Sept. 23, 2026
Image
Natalie Scholpa

Natalie Scholpa, PhD, an assistant research professor with the R. Ken Coit College of Pharmacy, has been announced as the recipient of the Arizona Biomedical Research Centre (ABRC) New Investigator Award. This award is provided through a competitive grant process aimed to accelerate research toward clinical testing and breakthroughs designed to improve the health of Arizonans.

“Receiving the Arizona Biomedical Research Centre New Investigator Award is incredibly meaningful to me, both because of the research it will enable me to accomplish and because of what it represents at this stage in my career,” shared Scholpa. In addition to her position with the college’s Department of Pharmacology & Toxicology, she is also a research health scientist with the Southern Arizona VA Healthcare System. “This award gives me the opportunity to continue building my independent research program and to move a promising new approach for pain management forward. It also provides an important foundation for future studies and larger funding opportunities.”

The funding associated with the award will support Scholpa’s project “Development of MARY1, a novel and selective serotonin 2B receptor antagonist, for non-opioid pain management”. The study will investigate MARY1 as a potential non-opioid treatment for inflammatory and neuropathic pain and will evaluate how well MARY1 reduces pain, how it works, and its safety, with the goal of determining whether it should be advanced for further development. Scholpa serves as the Principal Investigator.

The New Investigator Award (NIA) helps new investigators build their research programs and generate the early results needed to pursue further grants, making it a particularly exciting opportunity for Scholpa. Her promising early findings with MARY1, combined with the open grant applications, inspired her to take the next step and explore its potential as a new approach to pain management. Applications were evaluated based on scientific merit and approach, innovation and collaboration, the research environment, the qualifications and experience of the investigator, and the potential of the research to improve the health of Arizona residents. Scholpa is one of eight applicants associated with the University of Arizona to receive this award.

The NIA was established to help new investigators with less than ten years of postdoctoral experience conduct research to generate preliminary data for future projects and applications. For researchers early in their career, Scholpa believes awards like the NIA are especially valuable. “This type of funding provides early-career investigators with the resources and momentum needed to generate data and continue building an independent research program,” she added. “For me, that support comes at an important point in my career.”

In addition to Scholpa, two fellow UA faculty will collaborate on the project: Tally Largent-Milnes, PhD, who brings expertise in preclinical pain models and behavioral assessment of pain, and Rick Schnellmann, PhD, who provides mentorship as well as extensive expertise in mitochondrial biology, pharmacology, and the development of MARY1. Scholpa shared her appreciation for their dedicated support during this pivotal moment in her research career: “I am especially grateful to Dr. Largent-Milnes, who first brought the NIA opportunity to my attention, and to Dr. Schnellmann, whose mentorship and support have been instrumental in my development as a scientist and independent investigator.”